Cargando…
Drug Repurposing of the Anthelmintic Niclosamide to Treat Multidrug-Resistant Leukemia
Multidrug resistance, a major problem that leads to failure of anticancer chemotherapy, requires the development of new drugs. Repurposing of established drugs is a promising approach for overcoming this problem. An example of such drugs is niclosamide, a known anthelmintic that is now known to be c...
Autores principales: | Hamdoun, Sami, Jung, Philipp, Efferth, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344920/ https://www.ncbi.nlm.nih.gov/pubmed/28344555 http://dx.doi.org/10.3389/fphar.2017.00110 |
Ejemplares similares
-
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
por: Miner, Kent, et al.
Publicado: (2019) -
Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori
por: Tharmalingam, Nagendran, et al.
Publicado: (2018) -
Niclosamide as a Repurposing Drug against Corynebacterium striatum Multidrug-Resistant Infections
por: Folliero, Veronica, et al.
Publicado: (2022) -
Repurposing anthelmintic agents to eradicate resistant leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2020) -
Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology
por: Dawood, Mona, et al.
Publicado: (2018)